Linked Life Data

17237252

Source:http://linkedlifedata.com/resource/pubmed/id/17237252

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17237252rdf:typepubmed:Citationlld:pubmed
pubmed-article:17237252lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:17237252lifeskim:mentionsumls-concept:C0376466lld:lifeskim
pubmed-article:17237252lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:17237252lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:17237252lifeskim:mentionsumls-concept:C1883709lld:lifeskim
pubmed-article:17237252pubmed:issue5lld:pubmed
pubmed-article:17237252pubmed:dateCreated2007-5-9lld:pubmed
pubmed-article:17237252pubmed:abstractTextProtein kinase A (PKA) activation has been implicated in early-phase ischemic preconditioning. We recently found that during ischemia PKA activation causes inactivation of cytochrome-c oxidase (CcO) and contributes to myocardial damage due to ischemia-reperfusion. It may be that beta-adrenergic stimulation during ischemia via endogenous catecholamine release activates PKA. Thus beta-adrenergic stimulation may mediate both myocardial protection and damage during ischemia. The present studies were designed to determine the role of the beta(1)-adrenergic receptor (beta(1)-AR) in myocardial ischemic damage and ischemic preconditioning. Langendorff-perfused rabbit hearts underwent 30-min ischemia by anterior coronary artery ligation followed by 2-h reperfusion. Occlusion-reperfusion damage was evaluated by delineating the nonperfused volume of myocardium at risk and volume of myocardial necrosis after 2-h reperfusion. In some hearts ischemic preconditioning was accomplished by two 5-min episodes of global low-flow ischemia separated by 10 min before coronary occlusion-reperfusion. Orthogonal electrocardiograms were recorded, and coronary flow was monitored by a drip count. Three hearts from each experimental group were used to determine mitochondrial CcO and aconitase activities. Two-hour reperfusion after occlusion caused an additional decrease in CcO activity vs. that after 30-min occlusion alone. Blocking the beta(1)-AR during occlusion-reperfusion reversed CcO activity depression and preserved myocardium at risk for necrosis. Similarly, mitochondrial aconitase activity exhibited a parallel response after occlusion-reperfusion as well as for the other interventions. Furthermore, classic ischemic preconditioning had no effect on CcO depression. However, blocking the beta(1)-AR during preconditioning eliminated the cardioprotection. If the beta(1)-AR was blocked after preconditioning, the myocardium was preserved. Interestingly, in both of the latter cases the depression in CcO activity was reversed. Thus the beta(1)-AR plays a dual role in myocardial ischemic damage. Our findings may lead to therapeutic strategies for preserving myocardium at risk for infarction, especially in coronary reperfusion intervention.lld:pubmed
pubmed-article:17237252pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17237252pubmed:languageenglld:pubmed
pubmed-article:17237252pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17237252pubmed:citationSubsetIMlld:pubmed
pubmed-article:17237252pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17237252pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17237252pubmed:statusMEDLINElld:pubmed
pubmed-article:17237252pubmed:monthMaylld:pubmed
pubmed-article:17237252pubmed:issn0363-6135lld:pubmed
pubmed-article:17237252pubmed:authorpubmed-author:Anandatheerth...lld:pubmed
pubmed-article:17237252pubmed:authorpubmed-author:AvadhaniNaray...lld:pubmed
pubmed-article:17237252pubmed:authorpubmed-author:SpearJoseph...lld:pubmed
pubmed-article:17237252pubmed:authorpubmed-author:RazaHaiderHlld:pubmed
pubmed-article:17237252pubmed:authorpubmed-author:GalatiDomenic...lld:pubmed
pubmed-article:17237252pubmed:authorpubmed-author:PrabuSubbuswa...lld:pubmed
pubmed-article:17237252pubmed:issnTypePrintlld:pubmed
pubmed-article:17237252pubmed:volume292lld:pubmed
pubmed-article:17237252pubmed:ownerNLMlld:pubmed
pubmed-article:17237252pubmed:authorsCompleteYlld:pubmed
pubmed-article:17237252pubmed:paginationH2459-66lld:pubmed
pubmed-article:17237252pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:17237252pubmed:meshHeadingpubmed-meshheading:17237252...lld:pubmed
pubmed-article:17237252pubmed:meshHeadingpubmed-meshheading:17237252...lld:pubmed
pubmed-article:17237252pubmed:meshHeadingpubmed-meshheading:17237252...lld:pubmed
pubmed-article:17237252pubmed:meshHeadingpubmed-meshheading:17237252...lld:pubmed
pubmed-article:17237252pubmed:meshHeadingpubmed-meshheading:17237252...lld:pubmed
pubmed-article:17237252pubmed:meshHeadingpubmed-meshheading:17237252...lld:pubmed
pubmed-article:17237252pubmed:meshHeadingpubmed-meshheading:17237252...lld:pubmed
pubmed-article:17237252pubmed:year2007lld:pubmed
pubmed-article:17237252pubmed:articleTitlebeta1-Adrenoreceptor activation contributes to ischemia-reperfusion damage as well as playing a role in ischemic preconditioning.lld:pubmed
pubmed-article:17237252pubmed:affiliationDepartment of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia PA 19104-6046, USA. spearj@vet.upenn.edulld:pubmed
pubmed-article:17237252pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17237252pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17237252lld:pubmed